The race to commercialize brain-computer interfaces (BCIs) is accelerating globally, moving rapidly from science fiction into clinical reality[cite: 5]. While American companies secured an early head start in human trials, China is rapidly closing the gap through aggressive clinical progress, strategic commercial partnerships, and powerful state backing[cite: 5]. Understanding Brain-Computer Interfaces (BCIs) At its core,…